TEDCO, Maryland’s economic engine for technology companies, announced a recent State Small Business Credit Initiative (SSBCI) investment of $150,000 into JuneBrain Inc., an organization focused on creating new ways for physicians to remotely monitor their patients.
This is Part Two of our series on the vibrant Baltimore medtech ecosystem gaining significant momentum in Baltimore. Part One featured five exciting companies, including CoapTech, JuneBrain, ClearMask, LifeSprout, and NextStep Robotics.
BioBuzz has been reporting on myriad medtech university system spinouts and maturing companies from the Baltimore area for a number of years; we’ve featured a number of exciting and promising individual companies. However, as we’ve stepped back a bit to examine more recent Baltimore biohub developments, it’s become clear that there is an unmistakable groundswell of medtech activity that’s transforming the Baltimore life sciences sector.
The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.
JuneBrain is located in Baltimore and was founded by Dr. Samantha Scott in 2017. The company is a medtech startup that has the potential to improve the lives of the nearly 500 million patients suffering from neurological and retinal diseases. Dr. Scott has developed a prototype for a wearable, telehealth eye-scanning solution that allows providers to identify new disease activity outside of the clinic for patients suffering from diseases like multiple sclerosis (MS) and age-related macular degeneration (AMD), among others.
As we noted in our previous story, “Diversity in Biotech, Industry’s Next Big Challenge,” there is a deep, rich, underappreciated history of African-American innovation in the life sciences and STEM fields.
